ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,348, issued on June 23, was assigned to Dr. Falk Pharma GmbH (Freiburg, Germany) and Zedira GmbH (Darmstadt, Germany).
"Systemic formulation of a pyridinone derivate for TG2-related diseases" was invented by Roland Greinwald (Kenzingen, Germany), Martin Hils (Darmstadt, Germany), Wolfgang Mohr (Freiburg, Germany), Ralf Pasternack (Griesheim, Germany), Bernhard Tewes (Vorstetten, Germany) and Rudolf Wilhelm (Bischweier, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a formulation in particular an oral formulation for the prophylaxis and treatment of TG2-related disorders like fibrosis in particular diabetic ne...